Patient Engagement
This is the second article in a series regarding process-based opportunities as the healthcare industry begins to emerge from the challenges of the pandemic.
With Google Health and Apple both reported to be, respectively, closing down and scaling back their healthcare efforts, it's worth asking just how disruptive consumer technology companies can be in this hugely complex and fragmented industry.
_0.jpg?itok=3dBCNWIq)
The right technology applications can turn the COVID-19 vaccination program into a game-changer for the healthcare industry.
The development of PennOpen Pass, a symptom tracker and exposure alert system, offers a lesson on how challenging factors can focus the mind, enabling development of new tools that meet communities' needs.
With its promise of virtual care in all 50 states, this is the first time a big tech firm will be directly in the healthcare services business. Will it be another failed experiment, or the breakthrough we've been waiting for?
What still seems to be missing from the criteria is any assessment of the evidence of how well a product works and to what extent, says Prof Sam Shah, chief medical strategy officer, Numan.
We are witnessing a race in the vaccine rollout. A race towards the light at the end of a tunnel and a race which will likely define the next few years, according to Dr Charles Alessi, chief clinical officer at HIMSS.
At Geisinger in Pennsylvania, a pilot program to bring care to the homes of older patients with complex healthcare needs has shown a 35% reduction in visit
_0.jpg?itok=wr9tPZnO)
Mature health systems recognize the importance of context and design virtual care programs accordingly. Telehealth looks different for millennials and retirees, rural and urban patients and population groups with fundamentally different healthcare needs.
We start 2021 with hope and well-founded optimism, despite the ravages of the pandemic, reflects Dr Charles Alessi, chief clinical officer at HIMSS.
